← Eichor
Condition: Primary Hypercholesterolemia Or Mixed Dyslipidemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Primary Hypercholesterolemia Or Mixed Dyslipidemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipide
Phase 3 · 1 location(s) · A. Menarini International Licensing S.A. · NCT07614958A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · 163 location(s) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
Phase N/A · 4 location(s) · Novartis Pharmaceuticals · NCT06770543A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholes
Phase 3 · 2 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07421297
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.